These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31451475)

  • 1. Rhabdomyolysis: a rare adverse effect of levetiracetam.
    Thomas L; Mirza MMF; Shaikh NA; Ahmed N
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam Induced Increase in Creatine Phosphokinase Levels.
    Shahbaz N; Younus SM; Khan SA; Ain Q-; Khan MA; Memon MH
    J Coll Physicians Surg Pak; 2017 Mar; 27(3):S63-S64. PubMed ID: 28302251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review.
    Moinuddin IA
    Am J Case Rep; 2020 Oct; 21():e926064. PubMed ID: 33112844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuspected rhabdomyolysis associated with phenytoin.
    Santos-Calle FJ; Borrás-Blasco J; Navarro-Ruiz A; Plaza Macias I
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):436-40. PubMed ID: 16163896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Levetiracetam on Cognitive Function and Clonic Seizure Frequency in Children with Epilepsy.
    Zhou S; Zhan Q; Wu X
    Curr Mol Med; 2019; 19(9):699-703. PubMed ID: 31362674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyolysis associated with levetiracetam administration.
    Di Lorenzo R; Li Y
    Muscle Nerve; 2017 Jul; 56(1):E1-E2. PubMed ID: 28039868
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.
    Shorvon SD; Bermejo PE; Gibbs AA; Huberfeld G; Kälviäinen R
    Epilepsy Behav; 2018 May; 82():91-103. PubMed ID: 29602083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Management of Rhabdomyolysis in the Absence of Creatine Phosphokinase: A Medical Record Review.
    Chandel A; Brusher K; Hall V; Howard RS; Clark PA
    Mil Med; 2019 Dec; 184(11-12):820-825. PubMed ID: 31090905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients.
    Akiyama K; Kume T; Fukaya M; Shiki I; Enami T; Tatara R; Shino M; Ikeda T
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):717-721. PubMed ID: 30083882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyolysis-Associated Acute Kidney Injury With Normal Creatine Phosphokinase.
    Kamal F; Snook L; Saikumar JH
    Am J Med Sci; 2018 Jan; 355(1):84-87. PubMed ID: 29289268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam-Related Alcohol Abuse in a Postencephalitic Patient.
    Guillama-Henríquez A; Hernandez-Huerta D; Alonso-Sánchez EB
    J Clin Psychopharmacol; 2020; 40(6):632-634. PubMed ID: 33044354
    [No Abstract]   [Full Text] [Related]  

  • 17. Two Manic Episodes Related to a Levetiracetam-Based Treatment in a 34-Year-Old Female Patient: A Case Report.
    Meyrel M; Veyrier M; Nieto I; Bellivier F; Geoffroy PA
    J Clin Psychopharmacol; 2019; 39(1):87-88. PubMed ID: 30418254
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam as a possible contributor to acute kidney injury.
    Spengler DC; Montouris GD; Hohler AD
    Clin Ther; 2014 Aug; 36(8):1303-6. PubMed ID: 24986483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Case of Levetiracetam and Drug-Induced Idiopathic Aseptic Meningitis in a Pediatric Patient.
    McDonald D; Sultan R; Viswanathan A; Siu A
    Pharmacotherapy; 2019 Jan; 39(1):109-113. PubMed ID: 30488976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.